Product type
Ticagrelor is an active pharmaceutical ingredient (API) used primarily as an antiplatelet medication. It works by inhibiting platelet aggregation, which helps prevent blood clots in patients with acute coronary syndrome or those undergoing percutaneous coronary intervention. Ticagrelor is typically administered in tablet form and is often prescribed alongside aspirin to enhance its effectiveness in reducing cardiovascular events. The compound is synthesized through a series of chemical reactions that ensure its efficacy and safety for patient use.
| Chemical formula | C23H28F2N6O4S |
| Molecular weight | 522.57 g/mol |
| Purity | тЙе 98% |
| Form | Powder or crystalline form |
| Storage conditions | Cool, dry place, protected from light |
When selecting ticagrelor as an API, buyers should consider the required purity level, typically 98% or higher, and the form in which it is needed, such as powder or crystalline. It's also essential to specify the desired packaging and storage conditions to ensure product stability. Buyers may need to provide information on quantities required, as bulk orders may be subject to different pricing and availability.
Get quotes for Ticagrelor
Tell us your requirement тАФ quantity, specs and timeline тАФ and our team sources verified manufacturers and brings you the best quote.
Ticagrelor is primarily used as an antiplatelet medication to prevent blood clots.
It is typically administered in tablet form, often in combination with aspirin.
Ticagrelor should be stored in a cool, dry place, protected from light.
The typical purity level for ticagrelor is 98% or higher.
Yes, it is used in emergency medicine for patients with acute coronary syndrome.
Yes, ticagrelor is often used in clinical research related to cardiovascular health.